Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Fortrea Holdings
FTRE
$1.69B
| $2.41M | ﹤0.01% |
487,653
+168,974
| +53% | +$909K |
|
2677
CTS Corp
CTS
$1.79B
| $2.41M | ﹤0.01% |
56,479
+12,543
| +29% | +$507K |
|
2678
PUT
Ionis Pharmaceuticals
IONS
$9.28B
| $2.39M | ﹤0.01% |
60,600
| – | – |
|
2679
Driven Brands
DRVN
$2.12B
| $2.39M | ﹤0.01% |
136,283
-103,732
| -43% | -$1.78M |
|
2680
DXP Enterprises
DXPE
$3B
| $2.39M | ﹤0.01% |
27,298
+9,169
| +51% | +$764K |
|
2681
IMAX
IMAX
$2.92B
| $2.39M | ﹤0.01% |
85,569
-89,007
| -51% | -$2.31M |
|
|
SPTN
2682
DELISTED
SpartanNash
SPTN
| $2.39M | ﹤0.01% |
90,285
-12,740
| -12% | -$255K |
|
|
SKE
2683
Skeena Resources
SKE
$4.07B
| $2.39M | ﹤0.01% |
150,188
+116,191
| +342% | +$1.46M |
|
2684
Vir Biotechnology
VIR
$1.52B
| $2.39M | ﹤0.01% |
473,658
+262,035
| +124% | +$1.4M |
|
2685
Cipher Digital
CIFR
$6.9B
| $2.38M | ﹤0.01% |
497,500
+204,387
| +70% | +$661K |
|
|
GOGL
2686
DELISTED
Golden Ocean Group
GOGL
| $2.38M | ﹤0.01% |
324,850
+174,583
| +116% | +$1.32M |
|
2687
Old Second Bancorp
OSBC
$1.31B
| $2.37M | ﹤0.01% |
133,477
+37,514
| +39% | +$612K |
|
|
SAND
2688
DELISTED
Sandstorm Gold
SAND
| $2.36M | ﹤0.01% |
251,572
-64,568
| -20% | -$553K |
|
2689
Lindblad Expeditions
LIND
$2.26B
| $2.35M | ﹤0.01% |
201,320
+27,778
| +16% | +$275K |
|
2690
Calumet Specialty Products
CLMT
$4.29B
| $2.35M | ﹤0.01% |
149,021
+59,642
| +67% | +$758K |
|
2691
Thor Industries
THO
$4.11B
| $2.35M | ﹤0.01% |
26,429
-54,675
| -67% | -$4.32M |
|
2692
CALL
Brighthouse Financial
BHF
$3.42B
| $2.34M | ﹤0.01% |
43,600
-25,500
| -37% | -$1.43M |
|
2693
Alpha and Omega Semiconductor
AOSL
$916M
| $2.34M | ﹤0.01% |
91,222
+60,136
| +193% | +$1.31M |
|
2694
Global X Copper Miners ETF NEW
COPX
$7.97B
| $2.34M | ﹤0.01% |
51,906
-3,001
| -5% | -$120K |
|
|
SCHW
2695
CALL
Charles Schwab
SCHW
$190B
| $2.34M | ﹤0.01% |
25,600
-24,500
| -49% | -$2.05M |
|
2696
Globalstar
GSAT
$10.7B
| $2.34M | ﹤0.01% |
99,157
+30,421
| +44% | +$613K |
|
2697
Compass Diversified
CODI
$924M
| $2.33M | ﹤0.01% |
370,878
+286,848
| +341% | +$3.19M |
|
|
ECHO
2698
PUT
EchoStar
ECHO
$26.6B
| $2.33M | ﹤0.01% |
+84,000
| New | +$1.85M |
|
2699
Kura Oncology
KURA
$896M
| $2.33M | ﹤0.01% |
403,241
+209,267
| +108% | +$1.28M |
|
|
DMC
2700
Del Monte Corp
DMC
$1.44B
| $2.32M | ﹤0.01% |
71,710
+14,782
| +26% | +$486K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.